At a glance
- Originator Kumamoto University; Ono Pharmaceutical
- Class Piperazines; Spiro compounds
- Mechanism of Action CCR5 receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV-1 infections
Most Recent Events
- 09 Mar 2009 Discontinued - Preclinical for HIV-1 infections in Japan (unspecified route)
- 07 May 2002 Preclinical trials in HIV-1 infections in Japan (unspecified route)